| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc. | Director | Common Stock | 901,215 | $16,589,476 | $18.41 | 22 Oct 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics Inc. | 20 Oct 2021 | 3 | -$1,137,819 | 4 | Director | 22 Oct 2021, 21:42 |
| FDMT | 4D Molecular Therapeutics Inc. | 29 Sep 2021 | 5 | -$815,863 | 4 | Director | 01 Oct 2021, 16:34 |
| FDMT | 4D Molecular Therapeutics Inc. | 27 Sep 2021 | 5 | -$1,060,518 | 4 | Director | 29 Sep 2021, 16:05 |
| FDMT | 4D Molecular Therapeutics Inc. | 17 May 2021 | 1 | $0 | 4 | Director | 19 May 2021, 20:34 |